community download

"Developing clear and structured monitoring strategies that minimise risks and optimise compliance success rates"

 

Last year at the Pharma Compliance Europe 2014 event, Karolina Czernicka-Kuhl, Novo Nordisk, Head of Legal and Compliand Europe East, gave the presentation "Developing clear and structured monitoring strategies that minimise risks and optimise compliance success rates."
 
Karolina Czernicka-Kuhl outlines in her presentation:
  • Why monitoring?
  • What should be monitored?
  • How to monitor (who should monitor)?
  • Benefits and costs

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*
Company:*
Industry:
Country:*

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details


Privacy statement »
Manage your email preferences »
 

You will be emailed the document as an attachment (265Kb in size)